You appear to be offline. Some data may be unavailable until your connection is restored.
S&P 500 biotechnology stocks
of 5 stocks
Biotechnology companies develop medicines from living cells, such as proteins, antibodies, and gene and cell therapies. Bringing a new drug to market involves years of clinical trials and regulatory review.
The S&P 500 includes 5 biotechnology stocks in the Healthcare sector.
Last updated November 13, 2026
of 5 stocks
Sort by
| Symbol | Company | Market cap | Score | Price | Change |
|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | $138.7B | ScoreSign up to see scores | ||
| MRNA | Moderna Inc | $100.6B | ScoreSign up to see scores | ||
| REGN | Regeneron Pharmaceuticals Inc | $99.2B | ScoreSign up to see scores | ||
| INCY | Incyte Corp | $24.9B | ScoreSign up to see scores | ||
| TECH | Bio-Techne Corp | $11.4B | ScoreSign up to see scores |
No results match No results match the selected filters
No stocks in this list are in this industry.
Other Healthcare industries
Scores are informational only and available with a TickStock account. See how stocks and ETFs are scored.
Track S&P 500 biotechnology stocks
Sign up to see the score for each stock and set up custom price, event, and news alerts delivered by email, push, or SMS.